Oncimmune Research Development vs Tax Provision Analysis

ONC Stock

14.75 0.05 0.34%

Oncimmune Holdings financial indicator trend analysis is much more than just breaking down Oncimmune Holdings plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncimmune Holdings plc is a good investment. Please check the relationship between Oncimmune Holdings Research Development and its Tax Provision accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncimmune Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Research Development vs Tax Provision

Research Development vs Tax Provision Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Oncimmune Holdings plc Research Development account and Tax Provision. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Oncimmune Holdings' Research Development and Tax Provision is -0.19. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Oncimmune Holdings plc, assuming nothing else is changed. The correlation between historical values of Oncimmune Holdings' Research Development and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Oncimmune Holdings plc are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Research Development i.e., Oncimmune Holdings' Research Development and Tax Provision go up and down completely randomly.

Correlation Coefficient

-0.19

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most indicators from Oncimmune Holdings' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncimmune Holdings plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncimmune Holdings plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

The current year's Tax Provision is expected to grow to about 269.3 K, whereas Selling General Administrative is forecasted to decline to about 474.1 K.

	2021	2022	2023	2024 (projected)
Interest Expense	943K	2.0M	2.3M	2.4M
Depreciation And Amortization	197K	981K	1.1M	1.2M

Interest Expense Depreciation And Amortization

Oncimmune Holdings fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Common Stock Shares Outstanding	Inventory	Short Term Debt	Net Tangible Assets	Long Term Debt	Net Receivables
Total Assets		0.74	0.07	0.68	0.42	0.78	-0.04	-0.83	0.59	0.64	0.85	0.64	0.75	0.46	0.38	0.41	0.7	0.76	0.95	0.76	0.36	0.51	0.45	0.14	0.14	0.7
Short Long Term Debt Total	0.74		0.19	0.63	0.08	0.74	0.25	-0.86	0.58	0.27	0.81	0.27	0.62	0.52	0.47	0.72	0.7	0.73	0.59	0.65	0.61	0.28	0.5	-0.13	0.45	0.48
Other Current Liab	0.07	0.19		-0.08	-0.26	0.27	0.33	0.0	-0.43	-0.14	0.22	-0.14	-0.03	0.64	-0.48	0.16	0.27	0.31	-0.04	-0.01	0.4	-0.29	-0.3	-0.35	0.73	0.61
Total Current Liabilities	0.68	0.63	-0.08		-0.23	0.81	0.5	-0.79	0.9	-0.01	0.83	-0.01	0.3	0.43	0.85	0.68	0.89	0.76	0.49	0.35	0.27	0.28	0.92	-0.32	0.14	0.55
Total Stockholder Equity	0.42	0.08	-0.26	-0.23		-0.14	-0.91	-0.14	-0.05	0.91	-0.04	0.91	0.41	-0.43	-0.27	-0.46	-0.35	-0.16	0.63	0.39	-0.22	0.45	-0.29	0.89	-0.38	-0.05
Property Plant And Equipment Net	0.78	0.74	0.27	0.81	-0.14		0.5	-0.87	0.64	0.11	0.95	0.11	0.59	0.7	0.53	0.79	0.91	0.98	0.57	0.62	0.54	0.42	0.67	-0.36	0.47	0.73
Net Debt	-0.04	0.25	0.33	0.5	-0.91	0.5		-0.22	0.29	-0.74	0.43	-0.74	-0.06	0.69	0.44	0.71	0.67	0.53	-0.31	-0.05	0.47	-0.21	0.49	-0.94	0.55	0.35
Retained Earnings	-0.83	-0.86	0.0	-0.79	-0.14	-0.87	-0.22		-0.8	-0.32	-0.89	-0.32	-0.66	-0.4	-0.6	-0.67	-0.75	-0.81	-0.67	-0.69	-0.39	-0.47	-0.68	0.02	-0.26	-0.5
Accounts Payable	0.59	0.58	-0.43	0.9	-0.05	0.64	0.29	-0.8		0.06	0.68	0.06	0.34	0.1	0.91	0.57	0.67	0.57	0.45	0.39	0.14	0.4	0.92	-0.08	-0.1	0.22
Cash	0.64	0.27	-0.14	-0.01	0.91	0.11	-0.74	-0.32	0.06		0.16	1.0	0.56	-0.12	-0.16	-0.24	-0.06	0.08	0.84	0.52	-0.13	0.4	-0.18	0.76	-0.35	0.17
Non Current Assets Total	0.85	0.81	0.22	0.83	-0.04	0.95	0.43	-0.89	0.68	0.16		0.16	0.64	0.67	0.54	0.71	0.91	0.94	0.63	0.68	0.6	0.44	0.67	-0.32	0.5	0.77
Cash And Short Term Investments	0.64	0.27	-0.14	-0.01	0.91	0.11	-0.74	-0.32	0.06	1.0	0.16		0.56	-0.12	-0.16	-0.24	-0.06	0.08	0.84	0.52	-0.13	0.4	-0.18	0.76	-0.35	0.17
Common Stock Total Equity	0.75	0.62	-0.03	0.3	0.41	0.59	-0.06	-0.66	0.34	0.56	0.64	0.56		0.44	0.19	0.41	0.42	0.64	0.7	0.96	0.58	0.69	0.15	0.05	0.15	0.34
Non Current Liabilities Total	0.46	0.52	0.64	0.43	-0.43	0.7	0.69	-0.4	0.1	-0.12	0.67	-0.12	0.44		0.11	0.64	0.78	0.76	0.27	0.42	0.7	-0.03	0.18	-0.69	0.66	0.76
Other Current Assets	0.38	0.47	-0.48	0.85	-0.27	0.53	0.44	-0.6	0.91	-0.16	0.54	-0.16	0.19	0.11		0.66	0.62	0.49	0.23	0.23	0.18	0.34	0.95	-0.3	-0.11	0.08
Other Stockholder Equity	0.41	0.72	0.16	0.68	-0.46	0.79	0.71	-0.67	0.57	-0.24	0.71	-0.24	0.41	0.64	0.66		0.79	0.81	0.18	0.45	0.65	0.26	0.67	-0.61	0.46	0.35
Total Liab	0.7	0.7	0.27	0.89	-0.35	0.91	0.67	-0.75	0.67	-0.06	0.91	-0.06	0.42	0.78	0.62	0.79		0.91	0.47	0.47	0.54	0.17	0.71	-0.54	0.44	0.76
Property Plant And Equipment Gross	0.76	0.73	0.31	0.76	-0.16	0.98	0.53	-0.81	0.57	0.08	0.94	0.08	0.64	0.76	0.49	0.81	0.91		0.54	0.69	0.66	0.45	0.6	-0.43	0.52	0.74
Total Current Assets	0.95	0.59	-0.04	0.49	0.63	0.57	-0.31	-0.67	0.45	0.84	0.63	0.84	0.7	0.27	0.23	0.18	0.47	0.54		0.7	0.17	0.49	0.26	0.39	-0.1	0.55
Common Stock	0.76	0.65	-0.01	0.35	0.39	0.62	-0.05	-0.69	0.39	0.52	0.68	0.52	0.96	0.42	0.23	0.45	0.47	0.69	0.7		0.64	0.69	0.21	0.05	0.21	0.39
Common Stock Shares Outstanding	0.36	0.61	0.4	0.27	-0.22	0.54	0.47	-0.39	0.14	-0.13	0.6	-0.13	0.58	0.7	0.18	0.65	0.54	0.66	0.17	0.64		0.34	0.16	-0.56	0.64	0.47
Inventory	0.51	0.28	-0.29	0.28	0.45	0.42	-0.21	-0.47	0.4	0.4	0.44	0.4	0.69	-0.03	0.34	0.26	0.17	0.45	0.49	0.69	0.34		0.34	0.16	-0.12	0.11
Short Term Debt	0.45	0.5	-0.3	0.92	-0.29	0.67	0.49	-0.68	0.92	-0.18	0.67	-0.18	0.15	0.18	0.95	0.67	0.71	0.6	0.26	0.21	0.16	0.34		-0.32	0.06	0.26
Net Tangible Assets	0.14	-0.13	-0.35	-0.32	0.89	-0.36	-0.94	0.02	-0.08	0.76	-0.32	0.76	0.05	-0.69	-0.3	-0.61	-0.54	-0.43	0.39	0.05	-0.56	0.16	-0.32		-0.55	-0.31
Long Term Debt	0.14	0.45	0.73	0.14	-0.38	0.47	0.55	-0.26	-0.1	-0.35	0.5	-0.35	0.15	0.66	-0.11	0.46	0.44	0.52	-0.1	0.21	0.64	-0.12	0.06	-0.55		0.54
Net Receivables	0.7	0.48	0.61	0.55	-0.05	0.73	0.35	-0.5	0.22	0.17	0.77	0.17	0.34	0.76	0.08	0.35	0.76	0.74	0.55	0.39	0.47	0.11	0.26	-0.31	0.54

Click cells to compare fundamentals

Oncimmune Holdings Account Relationship Matchups

Oncimmune Holdings fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.3M	24.3M	17.3M	8.4M	9.7M	10.2M
Other Current Liab	1.0M	1.2M	6K	722K	830.3K	634.2K
Total Current Liabilities	3.5M	9.8M	15.1M	1.4M	1.6M	1.6M
Total Stockholder Equity	(194K)	5.2M	(2.7M)	657K	755.6K	717.8K
Property Plant And Equipment Net	1.4M	1.6M	1.5M	591K	679.7K	617.1K
Net Debt	4.0M	837K	8.2M	2.1M	2.4M	2.5M
Retained Earnings	(65.5M)	(70.1M)	(79.6M)	(42.5M)	(38.3M)	(40.2M)
Accounts Payable	420K	768K	2.0M	172K	197.8K	187.9K
Cash	4.2M	8.6M	2.5M	3.2M	3.7M	5.3M
Non Current Assets Total	4.1M	8.2M	7.3M	2.9M	3.3M	2.6M
Cash And Short Term Investments	4.2M	8.6M	2.5M	3.2M	3.7M	5.3M
Liabilities And Stockholders Equity	10.3M	24.3M	17.3M	8.4M	9.7M	10.2M
Non Current Liabilities Total	7.0M	9.3M	4.9M	6.4M	7.3M	7.7M
Other Current Assets	23K	427K	7.0M	199K	228.9K	217.4K
Other Stockholder Equity	64.6M	38.6M	76.2M	42.7M	49.1M	39.1M
Total Liab	10.5M	19.1M	20.0M	7.8M	8.9M	7.1M
Property Plant And Equipment Gross	1.4M	1.6M	1.5M	870K	1.0M	642.7K
Total Current Assets	6.2M	16.1M	10.0M	5.6M	6.4M	7.5M
Accumulated Other Comprehensive Income	(967K)	4.2M	(42K)	(223K)	(256.5K)	(269.3K)
Common Stock	635K	691K	695K	741K	852.2K	463.7K
Common Stock Shares Outstanding	63.3M	64.6M	64.5M	72.5M	83.4M	62.2M
Inventory	174K	143K	413K	235K	270.3K	193.7K
Net Tangible Assets	5.4M	(2.6M)	(467K)	(7.5M)	(6.8M)	(6.4M)
Net Receivables	1.8M	6.9M	1.7M	1.9M	2.2M	1.6M
Property Plant Equipment	422K	1.4M	1.6M	1.5M	1.8M	1.9M
Other Assets	356K	937K	927K	1.0	1.15	1.09
Deferred Long Term Liab	671K	512K	356K	196K	225.4K	379.3K
Intangible Assets	1.1M	4.1M	3.2M	483K	555.5K	527.7K
Non Currrent Assets Other	872K	3.4M	(937K)	483.0K	434.7K	664.3K
Net Invested Capital	7.1M	13.7M	7.2M	5.8M	5.2M	6.9M
Net Working Capital	2.8M	6.3M	(5.1M)	4.1M	3.7M	3.4M
Capital Stock	635K	691K	695K	741K	852.2K	746.9K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft

Other Information on Investing in Oncimmune Stock

Balance Sheet is a snapshot of the financial position of Oncimmune Holdings plc at a specified time, usually calculated after every quarter, six months, or one year. Oncimmune Holdings Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Oncimmune Holdings and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Oncimmune currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Oncimmune Research Development vs Tax Provision Analysis

Research Development vs Tax Provision

Research Development vs Tax Provision Correlation Analysis

Correlation Coefficient

Research Development

Tax Provision

Oncimmune Holdings fundamental ratios Correlations

Oncimmune Holdings Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Oncimmune Holdings fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Oncimmune Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Property Plant And Equipment Gross	+ 0.98	Property Plant And Equipment Net
Common Stock	+ 0.96	Common Stock Total Equity
Total Current Assets	+ 0.95	Total Assets
Non Current Assets Total	+ 0.95	Property Plant And Equipment Net
Short Term Debt	+ 0.95	Other Current Assets

Net Tangible Assets	- 0.94	Net Debt
Net Debt	- 0.91	Total Stockholder Equity
Non Current Assets Total	- 0.89	Retained Earnings
Retained Earnings	- 0.87	Property Plant And Equipment Net
Retained Earnings	- 0.86	Short Long Term Debt Total
Retained Earnings	- 0.83	Total Assets